Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2024 06:00 ET | Source: Smart Immune

Smart Immune treats adult acute leukemia patient at final dose level in Phase I/II ReSET-02 trial

Smart Immune treats adult acute leukemia patient at final dose level in Phase I/II ReSET-02 trial PARIS, France, May 2, 2024 – Smart Immune, a clinical-stage biotechnology company developing...